Gene polymorphisms of TNF-α⁻³⁰⁸ (G/A), IL-10⁻¹⁰⁸² (G/A), IL-6⁻¹⁷⁴ (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus

References

• Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001; 414(6865)792–798
   PubMed Web of Science ®Google Scholar
• Pitkaniemi J, Moltchanova E, Haapala L, Harjutsalo V, Tuomilehto J, Hakulinen T. Genetic random effects model for family data with long-term survivors: Analysis of diabetic nephropathy in type 1 diabetes. Genet Epidemiol 2007; 31(7)697–708
   PubMedGoogle Scholar
• Soria J, Garagorri JM, Rodriguez M, Rodriguez G, Larrad L, Elizalde M. Epidemiology and genetic risk of type 1 diabetes among children in Aragon community, Spain. Diabetes Res Clin Pract 2007; 79(1)112–116
   PubMedGoogle Scholar
• Berg AK, Korsgren O, Frisk G. Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection. Diabetologia 2006; 49(11)2697–2703
   PubMedGoogle Scholar
• Christen U. Chemokines as drug targets in type 1 diabetes. Endocr Metab Immune Disord Drug Targets 2007; 7(1)7–12
   PubMedGoogle Scholar
• Reddy S, Young M. IL-1ß expression in islet cells of mouse and its spatial relationship to beta cells and inducible nitric oxide synthase. Ann N Y Acad Sci 2002; 958: 190–193
   PubMed Web of Science ®Google Scholar
• Kainonen E, Rautava S, Korkeamaki M, Isolauri E. Unique cytokine secretion profile in children with both type I diabetes and asthma distinct from that of solely diabetic or asthmatic children. Cytokine 2006; 34(3–4)198–205
   PubMedGoogle Scholar
• Ramadas RA, Li X, Shubitowski DM, Samineni S, Wills-Karp M, Ewart SL. IL-1 receptor antagonist as a positional candidate gene in a murine model of allergic asthma. Immunogenetics 2006; 58(10)851–855
   PubMedGoogle Scholar
• Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403–404
   PubMed Web of Science ®Google Scholar
• Gillespie KM, Nolsoe R, Betin VM, Kristiansen OP, Bingley PJ, Mandrup-Poulsen T, Gale EA. Is puberty an accelerator of type 1 diabetes in IL6− 174CC females?. Diabetes 2005; 54(4)1245–1248
   PubMedGoogle Scholar
• Wastowski IJ, Peres NT, Simões RT, Castelli EC, Simões AL, Martinez-Rossi NM, Donadi EA. Identification of a novel 120 bp allele at the TNFd microsatellite locus. Tissue Antigens 2006; 67(4)318–320
   PubMedGoogle Scholar
• Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001; 62(11)1191–1199
   PubMed Web of Science ®Google Scholar
• Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102(7)1369–1376
   PubMed Web of Science ®Google Scholar
• Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993; 90(8)3725–3729
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765
   PubMed Web of Science ®Google Scholar
• Yu L, Yang MS, Zhao J, Shi YY, Zhao XZ, Yang JD, Liu ZJ, Gu NF, Feng GY, He L. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 2004; 71(1)179–183
   PubMedGoogle Scholar
• Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42(6)1101–1108
   PubMed Web of Science ®Google Scholar
• Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94(11)3941–3946
   PubMed Web of Science ®Google Scholar
• Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP 2000; 1(2)24–35
   PubMedGoogle Scholar
• Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98(5)1594–1600
   PubMed Web of Science ®Google Scholar
• Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999; 189(12)1863–1874
   PubMedGoogle Scholar
• Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: A review. Crit Rev Immunol 1998; 18(5)389–418
   PubMed Web of Science ®Google Scholar
• Kumar R, Goswami R, Agarwal S, Israni N, Singh SK, Rani R. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 2007; 69(6)557–567
   PubMedGoogle Scholar
• Siekiera U, Jarosz-Chobot P, Janusz J, Koehler B. Polymorphism of TNF-alpha (308 A/G), IL-10 (1082 A/G, 819 C/T 592 A/C), IL-6 (174 G/C), and IFN-gamma (874 A/T); genetically conditioned cytokine synthesis level in children with diabetes type 1. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2002; 8(1)29–34
   PubMedGoogle Scholar
• Deng GY, Maclaren NK, Huang HS, Zhang LP, She JX. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum Immunol 1996; 45(2)137–142
   PubMedGoogle Scholar
• Zemunik T, Skrabic V, Boraska V, Diklic D, Terzic IM, Capkun V, Peruzovic M, Terzic J. FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. J Mol Diagn 2005; 7(5)600–604
   PubMedGoogle Scholar
• Kristiansen OP, Pociot F, Johannesen J, Bergholdt R, Dinarello CA, Nerup J. Linkage disequilibrium testing of four interleukin-1 gene-cluster polymorphisms in Danish multiplex families with insulin-dependent diabetes mellitus. Cytokine 2000; 12(2)171–175
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello CA, Nerup J. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994; 43(10)1242–1247
   PubMedGoogle Scholar
• Pociot F, Ronningen KS, Bergholdt R, Lorenzen T, Johannesen J, Ye K, Dinarello CA, Nerup J. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes—evidence for polygenicity in man. Danish Study Group of Diabetes in childhood. Autoimmunity 1994; 19(3)169–178
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996; 39(9)1005–1029
   PubMedGoogle Scholar
• Ladner Martha B, Valdes Ana M, Bottini Nunzio, Cho Eunji, Noble Janelle A. PTPN22, CTLA4, MIF-1, IL6 and TCF7 polymorphisms and type 1 diabetes. Genetics 2004; 5: 1
   PubMedGoogle Scholar
• Hermann C, Krikovszky D, Füst G, Kovács M, Körner A, Szabó A, Vannay A, Madácsy L. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms. Eur Cytokine Netw 2005; 16(4)277–281
   PubMedGoogle Scholar
• Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20(10)885–888
   PubMedGoogle Scholar
• Reynier F, Cazalis MA, Lecoq A, Paye M, Rosa A, Durand A, Jhumka U, Mougin B, Miossec P, Bendelac N, Nicolino M, Thivolet C. Lack of association of IL-10 promoter gene variants with type 1 diabetes in a French population. Hum Immunol 2006; 67(4–5)311–317
   PubMedGoogle Scholar
• Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, Imaizumi M, Oshima K, Usa T, Uotani S, Ejima E, Yamasaki H, Ashizawa K, Yamaguchi Y, Eguchi K. Interleukin-10 gene promoter region polymorphisms in patients with type 1 diabetes and autoimmune thyroid disease. Ann NY Acad Sci 2003; 1005: 344–347
   PubMedGoogle Scholar
• Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Sakamaki H, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 2002; 63(8)690–695
   PubMedGoogle Scholar
• Urcelay E, Santiago JL, de la Calle H, Martínez A, Figueredo A, Fernández-Arquero M, de la Concha EG. Interleukin-10 polymorphisms in Spanish type 1 diabetes patients. Genes Immun 2004; 5(4)306–309
   PubMedGoogle Scholar